Name: CLOV Income Statement - Clover Health Investments, Corp. /de Revenue & EPS | Ledgeburg
Creator: Ledgeburg
License: https://creativecommons.org/licenses/by/4.0/
Keywords: Revenue, Cost of Revenue, Gross Profit, Operating Expenses, Operating Income, Net Income, EPS Basic, EPS Diluted

JavaScript is disabled. Some features may not work properly. For the best experience, please enable JavaScript in your browser.

CLOV - Clover Health Investments, Corp. /de

USD | NASDAQ | Financial Services

CLOV Income Statement - Clover Health Investments, Corp. /de Revenue & EPS | Ledgeburg

(in millions of USD, except per-share data)	Q1 FY 26	Q4 FY 25	Q3 FY 25	Q2 FY 25	Q1 FY 25	Q4 FY 24	Q3 FY 24	Q2 FY 24	Q1 FY 24	Q4 FY 23	Q3 FY 23	Q2 FY 23	Q1 FY 23	Q4 FY 22	Q3 FY 22	Q2 FY 22	Q1 FY 22	Q4 FY 21	Q3 FY 21	Q2 FY 21	Q1 FY 21	Q4 FY 20	Q3 FY 20	Q2 FY 20	Q1 FY 20
Revenues
Revenues	749.2	487.7	496.7	477.6	462.3	337.0	331.0	356.3	346.9	312.4	306.0	320.1	322.0	(1,481.3)	856.8	846.7

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

(in millions of USD, except per-share data)	TTM	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019
Revenues
Revenues	2,211.2	1,924.3	1,371.1	1,260.5	1,096.6	1,472.0	672.9	462.3
Cost of Revenue	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-
Operating Expenses
Research & Development	-	-	-	-	-	-	-	-
Selling General & Administrative	-	-	-	-	-
Operating Income
Operating Income	(56.9)	(85.5)	(45.7)	(205.3)	(286.7)	(637.0)	(92.7)	(183.2)
Non-Operating
Interest Income	-	-	-	-	-	-	0.1	-
Interest Expense	-	0.0	0.0	0.0	1.3	3.2
Tax & Net
Income Tax Expense	-	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Net Income From Continuing Ops	(56.9)	(85.5)	(46.3)	(210.1)	(254.6)
Per Share
EPS Basic	(0.11)	-	-	(0.44)	(0.71)	(1.42)	(1.54)	(4.14)
EPS Diluted	(0.11)	-	-	(0.44)	(0.71)	(1.42)
Supplementary Data
EBITDA	(55.2)	(83.8)	(44.4)	(202.8)	(285.5)	(635.7)	(92.2)	(182.6)
EBIT	(56.9)	(85.5)	(45.7)	(205.3)	(286.7)	(637.0)

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

Operating Expenses
Research & Development	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Selling General & Administrative	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Selling & Marketing	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
General & Administrative	74.6	66.2	49.0	48.5	50.7	52.3	35.2	44.4	44.6	42.7	41.0	41.7	57.6	51.1	47.8	47.0	57.7
Depreciation & Amortization	0.5	0.4	0.4	0.4	0.5	0.3	0.3	0.3	0.3	0.7	0.6	1.0	0.3	(0.8)	0.6	0.6
Amortization of Intangibles	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Operating Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Operating Expenses	721.9	537.0	521.0	488.2	463.6	358.4	339.8	349.1	369.6	375.5	339.6	349.0	401.7	(1,459.0)	930.9

Operating Income
Operating Income	27.3	(49.3)	(24.4)	(10.6)	(1.3)	(21.4)	(8.8)	7.2	(22.7)	(63.1)	(33.6)	(28.9)	(79.7)	(22.4)	(74.1)	(102.7)	(87.5)	(186.8)	(149.3)	(181.9)	(119.1)	(67.6)	(21.6)	23.2	(26.6)

Tax & Net
Income Tax Expense	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income From Continuing Ops	27.3	(49.3)	(24.4)	(10.6)	(1.3)	(21.5)	(8.8)	7.2	(23.2)	(67.9)	(33.6)	(28.9)	(79.7)	0.8	(75.5)	(104.4)	(75.5)
Net Income From Discontinued Ops	-	0.0	0.0	0.0	0.0	(0.6)	(0.4)	0.2	4.0	(2.5)	(7.9)	0.1	7.1	-	-	-	-
Net Income	27.3	(49.3)	(24.4)	(10.6)	(1.3)	(22.1)	(9.2)	7.4	(19.2)	(70.5)	(41.5)	(28.8)	(72.6)	(84.2)	(75.5)	(104.4)	(75.5)
Net Income Attributable To Parent	27.3	(49.3)	(24.4)	(10.6)	(1.3)	(22.1)	(9.2)	7.4	(19.2)	(70.5)	(41.5)	(28.8)	(72.6)	(84.2)	(75.5)	(104.4)
Less: Minority Interest	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Less: Preferred Dividends	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income To Common Shareholders	27.3	(49.3)	(24.4)	(10.6)	(1.3)	(22.1)	(9.2)	7.4	(19.2)	(70.5)	(41.5)	(28.8)	(72.6)	(84.2)	(75.5)

Per Share
EPS Basic	0.05	-	-	-	0.00	-	-	-	-	-	(0.09)	(0.06)	(0.15)	-	(0.16)	(0.22)	(0.16)	-	(0.08)	(0.78)	(0.13)	-	0.06	0.02	-
EPS Diluted	0.05	-	-	-	0.00	-	-	-	-	-	(0.09)	(0.06)	(0.15)	-	(0.16)	(0.22)	(0.16)	-
Shares Basic	522.2	-	512.7	509.0	497.1	-	490.2	487.5	486.4	-	480.8	479.2	478.8	-	477.7	476.1	473.0	-
Shares Diluted	532.5	-	512.7	509.0	497.1	-	490.2	495.2	486.4	-	480.8	479.2	478.8	-	477.7	476.1	473.0	-

Supplementary Data
EBITDA	27.8	(48.9)	(24.0)	(10.2)	(0.8)	(21.1)	(8.4)	7.5	(22.4)	(62.5)	(33.1)	(27.9)	(79.4)	(23.2)	(73.5)	(102.1)	(86.7)	(185.9)	(149.1)	(181.7)	(118.9)	(67.5)	(21.5)	23.3	(26.5)
EBIT	27.3	(49.3)	(24.4)	(10.6)	(1.3)	(21.4)	(8.8)	7.2	(22.7)	(63.1)	(33.6)	(28.9)	(79.7)	(22.4)	(74.1)	(102.7)	(87.5)	(186.8)	(149.3)